Results 121 to 130 of about 19,037 (201)

Rosai-Dorfman disease: A rare presentation as an isolated axillary lymphadenopathy, a case report and literature review. [PDF]

open access: yesInt J Surg Case Rep
Rahmouni E   +5 more
europepmc   +1 more source

IgG4-Related Disease in Childhood: Clinical Presentation, Management, and Diagnostic Challenges. [PDF]

open access: yesChildren (Basel)
Taranto S   +5 more
europepmc   +1 more source

CD68-Negative Histiocytoses with Cardiac Involvement, Associated with COVID-19. [PDF]

open access: yesInt J Mol Sci
Mitrofanova L   +7 more
europepmc   +1 more source

The 2023 WHO updates on skin tumors: advances since the 2018 edition. [PDF]

open access: yesPathologica
Fortarezza F   +3 more
europepmc   +1 more source

Indeterminate Cell Histiocytosis of the Spine: A Case Report

open access: closedPediatric Neurosurgery, 2021
<b><i>Introduction:</i></b> Indeterminate cell histiocytosis is a rare neoplastic disease characterized by proliferation of dendritic cells that share morphologic and immunophenotypic features of Langerhans cells and non-Langerhans histiocytes.
D. Sheinberg   +3 more
semanticscholar   +4 more sources

Tick bite mimicking indeterminate cell histiocytosis

open access: closedPediatric Dermatology, 2017
AbstractTicks are a well‐known vector for viral, bacterial, and rickettsial infections, many of which are accompanied by cutaneous eruptions, but the bite itself can induce a spectrum of inflammatory reactions, including foreign body granuloma, tick bite alopecia, and cutaneous lymphoid hyperplasia.
Thomas Stringer   +5 more
semanticscholar   +4 more sources

Indeterminate cell histiocytosis treated with 0.5% delgocitinib ointment.

British Journal of Dermatology, 2023
Although delgocitinib has been used for atopic dermatitis, it is also effective for ICH, a rare CD207-/CD1a+ histiocyte proliferative disease.
H. Miura   +3 more
semanticscholar   +3 more sources

Home - About - Disclaimer - Privacy